Search
Search
About
Log in
Join
Experiences with
Ibrutinib
Posts
Communities
1,965 public posts
Filter results
Dr. Jeff Jones from OSU on ibrutinib resistance, combination therapy and treating asymptomatic CLL.
Jeff Jones, to discuss
ibrutinib
resistance, combination therapy and treating asymptomatic CLL. Our inaugural newsletter web site, "The CLL Tribune" was launched on Sept. 30th and the response has been wonderful.
Jeff Jones, to discuss
ibrutinib
resistance, combination therapy and treating asymptomatic CLL. Our inaugural newsletter web site, "The CLL Tribune" was launched on Sept. 30th and the response has been wonderful.
bkoffman
CLL CURE Hero
in
CLL Support
9 years ago
Cive James and Pill x
Ibrutinib
? His experience would help the case for NHS availability perhaps. Wish he would tell us!
Ibrutinib
? His experience would help the case for NHS availability perhaps. Wish he would tell us!
romarin
in
CLL Support
9 years ago
Initial Safety Report Finds Acceptable Safety With Ibrutinib for Asymptomatic, High-Risk CLL
However, the CLL subtype responds to treatment with
ibrutinib
as well as idelalisib, another novel oral kinase inhibitor.
However, the CLL subtype responds to treatment with
ibrutinib
as well as idelalisib, another novel oral kinase inhibitor.
AussieNeil
Administrator
in
CLL Support
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
IMBRUVICA® (ibrutinib) Awarded Prix Galien 2015 Best Pharmaceutical Agent
[i]"AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that IMBRUVICA® (
ibrutinib
) was awarded the prestigious Prix Galien 2015 Award for Best Pharmaceutical Agent.
[i]"AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that IMBRUVICA® (
ibrutinib
) was awarded the prestigious Prix Galien 2015 Award for Best Pharmaceutical Agent.
AussieNeil
Administrator
in
CLL Support
9 years ago
My life with CLL
My main concern at this point is the government's intention to remove
Ibrutinib
from the Cancer Drug Fund. Will the effect people like me who are already on this treatment?
My main concern at this point is the government's intention to remove
Ibrutinib
from the Cancer Drug Fund. Will the effect people like me who are already on this treatment?
newrider
in
CLL Support
9 years ago
Dr. Byrd on Ibrutinib trials
Byrd presents the long-term data from patients having received almost three years of treatment with
ibrutinib
for chronic lymphocytic leukemia.
Byrd presents the long-term data from patients having received almost three years of treatment with
ibrutinib
for chronic lymphocytic leukemia.
bkoffman
CLL CURE Hero
in
CLL Support
9 years ago
Phase I/II trial of IPH2201 checkpoint inhibitor in combination with ibrutinib opens for patients with relapsed or refractory CLL
[i]"This Phase Ib/IIa study is a multicenter open label trial of the combination of IPH2201 and
ibrutinib
in patients with relapsed or refractory Chronic Lymphocytic Leukemia.
[i]"This Phase Ib/IIa study is a multicenter open label trial of the combination of IPH2201 and
ibrutinib
in patients with relapsed or refractory Chronic Lymphocytic Leukemia.
AussieNeil
Administrator
in
CLL Support
9 years ago
Your Charity needs you
LETTER FOR YOUR MEMBER OF PARLIAMENT RE: Proposed delisting of Bendamustine and
Ibrutinib
from The Cancer Drugs Fund list. It's in our hands - now is our time. Fortune favours the brave. Jules A Man on a mission I am pretty persistent or / also a pain the arse but we need to do this.
LETTER FOR YOUR MEMBER OF PARLIAMENT RE: Proposed delisting of Bendamustine and
Ibrutinib
from The Cancer Drugs Fund list. It's in our hands - now is our time. Fortune favours the brave. Jules A Man on a mission I am pretty persistent or / also a pain the arse but we need to do this.
Hidden
in
CLL Support
9 years ago
CLLSA Campaign on CDF delisting decisions
We are still waiting to hear about the outcome of our appeal to oppose the delisting of Bendamustine and
Ibrutinib
from NCDF. The decision will be taken behind closed doors and will be informed close to the delisting date of 4 November.
We are still waiting to hear about the outcome of our appeal to oppose the delisting of Bendamustine and
Ibrutinib
from NCDF. The decision will be taken behind closed doors and will be informed close to the delisting date of 4 November.
MaudMarie
in
CLL Support
9 years ago
Ibrutinib
Is
Ibrutinib
a drug that you are on for life??
Is
Ibrutinib
a drug that you are on for life??
fish61
in
CLL Support
9 years ago
Your opportunity to support affordable access to Ibrutinib and Idelalisib for Aussies - Submissions close next Wed 7th October
Australia's November Pharmaceutical Benefits Advisory Committe (PBAC) meeting will consider listing Idelalisib and
Ibrutinib
for CLL patients.
Australia's November Pharmaceutical Benefits Advisory Committe (PBAC) meeting will consider listing Idelalisib and
Ibrutinib
for CLL patients.
AussieNeil
Administrator
in
CLL Support
9 years ago
Statistical analysis of REACH trial patients identifies Progression Free Survival prognostic factor for FCR patients
Why is this news about FCR - an 'old' immunochemotherapy treatment, so important now that we have non-chemotherapy treatments like
Ibrutinib
and Idelalisib? Many CLL specialists recognise that for some CLL patients, FCR may be a better choice.
Why is this news about FCR - an 'old' immunochemotherapy treatment, so important now that we have non-chemotherapy treatments like
Ibrutinib
and Idelalisib? Many CLL specialists recognise that for some CLL patients, FCR may be a better choice.
AussieNeil
Administrator
in
CLL Support
9 years ago
The inaugural CLL Tribune
Byrd on
ibrutinib
, Dr. Brown on idelalisib, and a lot more. Please let us know what you think of it as a whole or any particular articles. I would like feedback on the work I did in the BASICS section on what is CLL with text and linked videos. Want the next one to be even better.
Byrd on
ibrutinib
, Dr. Brown on idelalisib, and a lot more. Please let us know what you think of it as a whole or any particular articles. I would like feedback on the work I did in the BASICS section on what is CLL with text and linked videos. Want the next one to be even better.
bkoffman
CLL CURE Hero
in
CLL Support
9 years ago
Dr. Byrd on trial design and getting drugs to market
Byrd is has written a long Q+A on
ibrutinib
; Dr. Jennifer Brown gives practical advice on idelalisib; I cover the basics of just what is CLL/SLL and more in a monolog and transcription; plus several patients including WWW have written diverse and helpful articles.
Byrd is has written a long Q+A on
ibrutinib
; Dr. Jennifer Brown gives practical advice on idelalisib; I cover the basics of just what is CLL/SLL and more in a monolog and transcription; plus several patients including WWW have written diverse and helpful articles.
bkoffman
CLL CURE Hero
in
CLL Support
9 years ago
Bright future? Only if we keep pushing!
Because drugs such as
ibrutinib
and idelalisib and obinutuzumab are already approved in many countries and offer pretty spectacular results, pharmaceutical companies may be less willing to invest the billions of dollars it takes to bring a new drug to market.
Because drugs such as
ibrutinib
and idelalisib and obinutuzumab are already approved in many countries and offer pretty spectacular results, pharmaceutical companies may be less willing to invest the billions of dollars it takes to bring a new drug to market.
bkoffman
CLL CURE Hero
in
CLL Support
9 years ago
InPractice CLL reference update - Idelalisib+Ofatumumab for relapsed/refractory patients. (Another CLL reference worth bookmarking)
The comprehensive InPractice reference for diagnosing, monitoring and treating CLL is regularly updated, with the latest update incorporating the addition of ofatumumab to idelalisib in patients with relapsed/refractory CLL plus the initial results from HELIOS trial of
ibrutinib
added to BR.
The comprehensive InPractice reference for diagnosing, monitoring and treating CLL is regularly updated, with the latest update incorporating the addition of ofatumumab to idelalisib in patients with relapsed/refractory CLL plus the initial results from HELIOS trial of
ibrutinib
added to BR.
AussieNeil
Administrator
in
CLL Support
9 years ago
Bad knees, Baker's Cysts, and Good Times with CLL plus our newsletter, LRF Meeting in Brooklyn and Patient meeting in Seattle
Please take a look at my blog http://bkoffman.blogspot.com to understand my thoughts and research about my present misery and a possible bilateral knee replacement when you have CLL and are on
ibrutinib
.
Please take a look at my blog http://bkoffman.blogspot.com to understand my thoughts and research about my present misery and a possible bilateral knee replacement when you have CLL and are on
ibrutinib
.
bkoffman
CLL CURE Hero
in
CLL Support
9 years ago
Ibrutinib denied to new patients
All down to
Ibrutinib
. I am working in a demanding job working 10.5 hour shifts as a nurse. Where might I be if I had been denied Ibrutnib, I dread to think.
All down to
Ibrutinib
. I am working in a demanding job working 10.5 hour shifts as a nurse. Where might I be if I had been denied Ibrutnib, I dread to think.
Pennycam
in
CLL Support
9 years ago
Ibrutinib usage
When I last saw my haematologist he spoke of a treatment of ongoing
Ibrutinib
, until such time as its efficacy diminished. I have looked on the www and found nothing on this usage of
Ibrutinib
. Is there anyone out there on such a course?
When I last saw my haematologist he spoke of a treatment of ongoing
Ibrutinib
, until such time as its efficacy diminished. I have looked on the www and found nothing on this usage of
Ibrutinib
. Is there anyone out there on such a course?
Grembold
in
CLL Support
9 years ago
My Take on 3 Interesting Papers on CLL from ASCO 2015
The three presentations are on a new prognostic scale, on a new non-chemo triplet therapy and finally on Bendamustine with and without
ibrutinib
. In the accompanying text, I go into more detail, and of course provide a link to the source material itself so we can all form our own opinions.
The three presentations are on a new prognostic scale, on a new non-chemo triplet therapy and finally on Bendamustine with and without
ibrutinib
. In the accompanying text, I go into more detail, and of course provide a link to the source material itself so we can all form our own opinions.
bkoffman
CLL CURE Hero
in
CLL Support
9 years ago
1
...
88
89
90
...
99
Next page
40
50
60
70
80
90
Filter results
Clear filters
Posted in
All communities
CLL Support
1877 results
Non Hodgkin's Lymphoma Friends
29 results
CLL America Support
28 results
View top 10 communities
Sort by
Most Relevant
Newest